Disorders of hyperpigmentation

A. G. Pandya, I. L. Guevara

Research output: Contribution to journalArticle

154 Citations (Scopus)

Abstract

Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement. Erythema dyschromicum perstans is a dermal pigmentation seen on the trunk and proximal extremities, most commonly presenting in dark-skinned Hispanics. Drug-induced and postinflammatory hyperpigmentation may last for many months after the offending drug or dermatitis has been eliminated. These disorders, including their management, is reviewed in this article.

Original languageEnglish (US)
Pages (from-to)91-95
Number of pages5
JournalDermatologic Clinics
Volume18
Issue number1
StatePublished - 2000

Fingerprint

Hyperpigmentation
Skin Pigmentation
Melanosis
Sunscreening Agents
Dermatitis
Erythema
Hispanic Americans
Pharmaceutical Preparations
Extremities
Gels
Skin
Therapeutics

ASJC Scopus subject areas

  • Dermatology

Cite this

Pandya, A. G., & Guevara, I. L. (2000). Disorders of hyperpigmentation. Dermatologic Clinics, 18(1), 91-95.

Disorders of hyperpigmentation. / Pandya, A. G.; Guevara, I. L.

In: Dermatologic Clinics, Vol. 18, No. 1, 2000, p. 91-95.

Research output: Contribution to journalArticle

Pandya, AG & Guevara, IL 2000, 'Disorders of hyperpigmentation', Dermatologic Clinics, vol. 18, no. 1, pp. 91-95.
Pandya AG, Guevara IL. Disorders of hyperpigmentation. Dermatologic Clinics. 2000;18(1):91-95.
Pandya, A. G. ; Guevara, I. L. / Disorders of hyperpigmentation. In: Dermatologic Clinics. 2000 ; Vol. 18, No. 1. pp. 91-95.
@article{c914c0cfb71643a8a1ee9bb64d6079b5,
title = "Disorders of hyperpigmentation",
abstract = "Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement. Erythema dyschromicum perstans is a dermal pigmentation seen on the trunk and proximal extremities, most commonly presenting in dark-skinned Hispanics. Drug-induced and postinflammatory hyperpigmentation may last for many months after the offending drug or dermatitis has been eliminated. These disorders, including their management, is reviewed in this article.",
author = "Pandya, {A. G.} and Guevara, {I. L.}",
year = "2000",
language = "English (US)",
volume = "18",
pages = "91--95",
journal = "Dermatologic Clinics",
issn = "0733-8635",
publisher = "W.B. Saunders Ltd",
number = "1",

}

TY - JOUR

T1 - Disorders of hyperpigmentation

AU - Pandya, A. G.

AU - Guevara, I. L.

PY - 2000

Y1 - 2000

N2 - Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement. Erythema dyschromicum perstans is a dermal pigmentation seen on the trunk and proximal extremities, most commonly presenting in dark-skinned Hispanics. Drug-induced and postinflammatory hyperpigmentation may last for many months after the offending drug or dermatitis has been eliminated. These disorders, including their management, is reviewed in this article.

AB - Hyperpigmentation is a common disorder of the skin, particularly in brown-skinned patients. Melasma is a common cause of facial hyperpigmentation and can be resistant to treatment. A combination of topical creams and gels, chemical peels, and sunscreens may be necessary for significant improvement. Erythema dyschromicum perstans is a dermal pigmentation seen on the trunk and proximal extremities, most commonly presenting in dark-skinned Hispanics. Drug-induced and postinflammatory hyperpigmentation may last for many months after the offending drug or dermatitis has been eliminated. These disorders, including their management, is reviewed in this article.

UR - http://www.scopus.com/inward/record.url?scp=0033962062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033962062&partnerID=8YFLogxK

M3 - Article

C2 - 10626115

AN - SCOPUS:0033962062

VL - 18

SP - 91

EP - 95

JO - Dermatologic Clinics

JF - Dermatologic Clinics

SN - 0733-8635

IS - 1

ER -